Author Correction: High- or low-dose preoperative ipilimumab plus nivolumab in stage III urothelial cancer: the phase 1B NABUCCO trial.

More about this publication

Nature medicine
  • Publication date 17-07-2023

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.